Skip to main content

Table 4 Causes of Death of Participants with Prior Heart Failure Hospitalization

From: Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone

  Chlorthalidone Treatment Group Doxazosin Treatment Group
No. of participants with hospitalization for heart failure prior to death* 280 317
   No. of deaths (%) 52 (18.6) 70 (22.1)
   Cause of death (%)   
Myocardial infarction 7 (13.5) 5 (7.1)
Definite CHD 5 (9.6) 9 (12.9)
Possible CHD 1 (1.9) 7 (10.0)
Stroke 1 (1.9) 3 (4.3)
Heart failure 11 (21.2) 12 (17.1)
Other CVD 4 (7.7) 7 (10.0)
Total cardiovascular deaths (%) 29 (55.8) 43 (61.4)
Cancer 8 (15.4) 6 (8.6)
Kidney disease 1 (1.9) 1 (1.4)
Accident/suicide/homicide 0 (0) 1 (1.4)
Other non-CVD 8 (15.4) 11 (15.7)
Unknown 6 (11.5) 8 (11.4)
  1. CHD = Coronary heart disease CVD = Cardiovascular disease *Excludes participants for whom death is the first reported heart failure event